Radiotherapy for cutaneous malignant lymphoma

Mitsuhiro Takemoto, T. Shinya, N. Katayama, K. Himei, M. Kuroda, S. Kanazawa, T. Oono, K. Iwatsuki, K. Shinagawa, M. Tanimoto, K. Ichimura, T. Yoshino

Research output: Contribution to journalReview articlepeer-review

Abstract

We reviewed consecutive 14 cases of cutaneous malignant lymphoma treated with 3-10MeV electron beams. B cell type and T cell type were each 7 cases. Two and five-year overall survival rates were 88.9% and 47.6%, respectively. Two and five-year progression free survival (PFS) rates were 55.6% and 27.8%. respectively. Early and late complications were observed each in one case. Univariate PFS analysis showed that lymph node(s) involvement, value of serum lactate dehydrogenase, previous chemotherapy and a number of irradiated field were significant prognostic factors.

Original languageEnglish
Pages (from-to)624-629
Number of pages6
JournalJapanese Journal of Clinical Radiology
Volume51
Issue number5
Publication statusPublished - May 29 2006

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Fingerprint Dive into the research topics of 'Radiotherapy for cutaneous malignant lymphoma'. Together they form a unique fingerprint.

Cite this